Motivation to smoking cessation in head and neck cancer and dysplasia patients in confrontation with the attitudes of otorhinolaryngologists in delivering anti-smoking therapies

Eur Arch Otorhinolaryngol. 2022 Jul;279(7):3645-3655. doi: 10.1007/s00405-021-07209-2. Epub 2021 Dec 10.

Abstract

Objectives: The aim of the study was to determine the influence of oral, oropharyngeal, laryngeal and hypopharyngeal dysplasia and cancer diagnosis on motivation to smoking cessation in patients. Consecutively, we assessed the competence of ENT specialists in counseling anti-smoking therapies.

Methods: Questionnaire of expected support, Schneider motivation test and Fagerström Test for Nicotine Dependence (FTND) were administered to 50 smoking patients. The online survey was collected from 152 ENT doctors.

Results: Mean FTND score was 4.58 and Heaviness of Smoking Index (HSI) was 3.1. Patients with oral cavity and oropharyngeal cancer showed the greatest dependence to nicotine 7.67 and 5.25, respectively, and with hypopharyngeal cancer had the lowest 3.5, (p = 0.039). The ranges of HSI were significantly higher for younger patients (p = 0.036). 35 patients were adequately motivated to quit smoking, and their mean age was statistically higher (p = 0.05). Self-reported motivation to smoking cessation was 76%. Of 152 surveyed doctors, only 39% declared knowledge of the diagnostic and therapeutic cessation interventions. 75% showed interest in the training programs.

Keywords: Anti-smoking therapy; Hypopharyngeal cancer; Laryngeal cancer; Laryngeal dysplasia; Oral cavity cancer; Oropharyngeal cancer; Smoking cessation.

MeSH terms

  • Attitude
  • Head and Neck Neoplasms* / therapy
  • Humans
  • Motivation
  • Smoking Cessation*
  • Tobacco Use Disorder* / diagnosis
  • Tobacco Use Disorder* / psychology